Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
49.64 SEK | +12.83% | +21.37% | +89.92% |
01:30pm | Hansa Biopharma Completes Randomization in Pivotal Phase 3 Us Confides Trial | CI |
05-21 | Hansa Biopharma to Present Data At 2024 American Transplant Congress Annual Meeting | CI |
End-of-day quotes
Sector Other Biotechnology & Medical Research
Capi. | Sales growth | Profitability | Finances | EV / Sales | P/E ratio | |
---|---|---|---|---|---|---|
262M | - | |||||
58.06B | - | |||||
40.53B | ||||||
38.99B | ||||||
26.7B | ||||||
26.56B |
- Stock Market
- Equities
- HNSA Stock
- Charts Hansa Biopharma AB
- Sector Chart